Table 1.
Ref. | Country | Sex (male/female) | Age (yr) | Median follow-up |
Cai et al[18], 2000 | Japan | 52/272 | 63 mea | 24 M |
Fukagawa et al[19], 2001 | Japan | 51/18 vs 22/163 | 57.8 ± 10.8 vs 59.8 ± 12.11 med | > 36 M |
Choi et al[20], 2002 | South Korea | 37/23 vs 19/93 | 59 mea | 26.3 vs 25.13 |
Lee et al[21], 2002 | Australia | NM | NM | NM |
Yasuda et al[22], 2002 | Japan | 30/14 vs 13/73 | NM | > 60 M |
Morgagni et al[23], 2003 | Italy | 111/119 | 68 med | 60 M |
Yonemura et al[24], 2007 | Japan | 198/110 | NM | 83 M |
Kim et al[25], 2008 | South Korea | 110/43 vs 21/103 | 54.7 ± 10.8 vs 52.0 ± 12.51 med | 83 M |
Ishii et al[26], 2008 | Japan | 23/12 | 62 med | 57.1 M |
Kim et al[27], 2009 | South Korea | 50/40 | 55.1 ± 12.2 vs 51.6 ± 12.31 mea | 49 vs 47 M3 |
Wang et al[28], 2012 | China | 43/22 vs 74/523 | 31.8 ± 10.9 vs 57.9 ± 13.01 mea | 45.6 M |
Jeuck et al[29], 2015 | Germany | 51/13 vs 28/33 | 66.3 mea | 56.4 vs 49.23 |
mean ± SD;
There are a total of 79 patients in this study and 10 patients were excluded because they suffered metastasis;
Lymph node micrometastasis (LNMM) negative vs positive. med: Median age; mea: Mean age; NM: Not mentioned.